Catherine Itoe, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-214-5548 |
Samina Shabnam, M.B.B.S. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-214-5548 |
Gurjeet Singh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-214-5548 |
Mahmuda Nasrin, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 13013 Fuller Ave Ste A, Grandview, MO 64030 Phone: 816-509-6694 |
News Archive
In recognition of November as National Diabetes Month, the American College of Occupational and Environmental Medicine (ACOEM) is urging employers to identify and respond to the impact of diabetes on worker health and productivity.
The number of new HIV infections among young people in Africa is falling in most of the "25 countries hardest hit by the virus," according to a report released Tuesday by UNAIDS, the Associated Press reports (Cheng, 7/13).
Genetically engineered fibers of the protein spidroin, which is the construction material for spider webs, has proven to be a perfect substrate for cultivating heart tissue cells, MIPT researchers found. They discuss their findings in an article that has recently come out in the journal PLOS ONE.
Researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital have identified several gene mutations responsible for the most common childhood brain tumor, called medulloblastoma, adding evidence to the theory that the diagnosis is a group of genetically distinct cancers with different prognoses. These and accompanying findings are likely to lead to less-toxic, better-targeted treatment approaches over the next two years, the researchers said.
AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces the publication of results from the first human phase 2 study of masitinib carried-out in the treatment of Alzheimer's disease.
› Verified 2 days ago